These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1525121)
21. Association of hemostatic factors with peripheral vascular disease. Philipp CS; Cisar LA; Kim HC; Wilson AC; Saidi P; Kostis JB Am Heart J; 1997 Nov; 134(5 Pt 1):978-84. PubMed ID: 9398113 [TBL] [Abstract][Full Text] [Related]
22. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Folsom AR; Conlan MG; Davis CE; Wu KK Ann Epidemiol; 1992 Jul; 2(4):481-94. PubMed ID: 1342299 [TBL] [Abstract][Full Text] [Related]
23. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Smith A; Patterson C; Yarnell J; Rumley A; Ben-Shlomo Y; Lowe G Circulation; 2005 Nov; 112(20):3080-7. PubMed ID: 16286603 [TBL] [Abstract][Full Text] [Related]
25. Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III. Ford ES; Giles WH J Clin Epidemiol; 2000 Jan; 53(1):95-102. PubMed ID: 10693909 [TBL] [Abstract][Full Text] [Related]
26. Hemostasis and atherosclerosis. Warkentin TE Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046 [TBL] [Abstract][Full Text] [Related]
27. The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group. Haverkate F; Thompson SG; van de Loo JC Ann Epidemiol; 1992 Jul; 2(4):521-4. PubMed ID: 1342302 [TBL] [Abstract][Full Text] [Related]
28. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Thompson SG; Fechtrup C; Squire E; Heyse U; Breithardt G; van de Loo JC; Kienast J Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):357-62. PubMed ID: 8630659 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184 [TBL] [Abstract][Full Text] [Related]
30. Reduced factor VII and factor VIII levels and prolonged thrombin-generation times during a healthy diet in middle-aged women with mild to moderate cardiovascular disease risk. Passaro A; Calzavarini S; Volpato S; Caruso P; Poli A; Fellin R; Bernardi F J Thromb Haemost; 2008 Dec; 6(12):2088-94. PubMed ID: 18823339 [TBL] [Abstract][Full Text] [Related]
31. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Grau AJ; Buggle F; Becher H; Werle E; Hacke W Thromb Res; 1996 May; 82(3):245-55. PubMed ID: 8732628 [TBL] [Abstract][Full Text] [Related]
32. Hemorheologic changes in patients with a history of stroke or cerebral remittent ischemic attacks. Coccheri S; Palareti G; Poggi M; Andreoli A; Fagioli L; Limoni P Ric Clin Lab; 1985; 15(1):39-46. PubMed ID: 3922040 [TBL] [Abstract][Full Text] [Related]
33. Atherothrombotic risk factor clustering in healthy male relatives of male patients with intermittent claudication. Parry DJ; Grant PJ; Scott DJ J Vasc Surg; 2004 Nov; 40(5):891-8. PubMed ID: 15557902 [TBL] [Abstract][Full Text] [Related]
34. [Hemostatic factors and family history of thrombosis in patients with a myocardial infarct: a case-control study. The participants in GISSI-2-Efrim. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico]. Iacoviello L; Roncaglioni MC; Amore C; Marfisi RM; Celardo A; Feruglio G; Franzosi MG; Tognoni G; Maseri A; Donati MB G Ital Cardiol; 1995 Jun; 25(6):769-76. PubMed ID: 7649426 [TBL] [Abstract][Full Text] [Related]
35. Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease. Christe M; Delley A; Marbet GA; Biland L; Duckert F Thromb Haemost; 1984 Dec; 52(3):240-2. PubMed ID: 6442467 [TBL] [Abstract][Full Text] [Related]
36. Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. Topol EJ; Easton JD; Amarenco P; Califf R; Harrington R; Graffagnino C; Davis S; Diener HC; Ferguson J; Fitzgerald D; Shuaib A; Koudstaal PJ; Theroux P; Van de Werf F; Willerson JT; Chan R; Samuels R; Ilson B; Granett J Am Heart J; 2000 Jun; 139(6):927-33. PubMed ID: 10827369 [TBL] [Abstract][Full Text] [Related]
37. [Fibrinogen. An old hemostatic protein with a new function: non-invasive marker of subclinical atherosclerosis]. Páramo JA; Rodríguez JA; Orbe J Med Clin (Barc); 2005 May; 124(20):790-4. PubMed ID: 15927107 [TBL] [Abstract][Full Text] [Related]
38. Association of lipoprotein(a) with atherothrombotic events and fibrinolytic variables. A case-control study. Franceschini G; Cofrancesco E; Safa O; Boschetti C; Tremoli E; Mussoni L; Sirtori CR; Cortellaro M Thromb Res; 1995 May; 78(3):227-38. PubMed ID: 7631303 [TBL] [Abstract][Full Text] [Related]
39. Hemostatic risk factors of coronary artery disease in the Chinese. Ho CH; Wang SP; Jap TS Int J Cardiol; 1995 Aug; 51(1):79-84. PubMed ID: 8522401 [TBL] [Abstract][Full Text] [Related]